Hidradenitis suppurativa - Hydradenitis Suppurativa
☆ AI Dermatology — Free Service
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
Hydradenitis Suppurativa (Hidradenitis suppurativa) (hatua ya I) kwenye kwapa. Hiki ni kisa kidogo sana cha Hydradenitis Suppurativa (Hidradenitis suppurativa).
relevance score : -100.0%
ReferencesHidradenitis suppurativa ni hali ya ngozi ambayo ni sugu, huwa inajirudia na inaweza kuathiri sana maisha yako. Husababishwa na kuvimba kwa vinyweleo, na mara nyingi husababisha maambukizo ya bakteria. Madaktari hugundua ugonjwa huo kwa kuangalia aina za vidonda ulivyonavyo (kama vile noduli (nodules), jipu, au mirija ya sinus (sinus tracts)), viko (kawaida kwenye mikunjo ya ngozi), na ni mara ngapi vinarudi na muda gani vinashikamana.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Matibabu yasiyo ya kibayolojia na yasiyo ya kitaratibu kwa kawaida hutumiwa peke yake kwa ugonjwa mdogo na yanaweza kuunganishwa na tiba ya kibayolojia na upasuaji kwa ugonjwa wa wastani hadi mbaya. Uchunguzi wa hivi majuzi unatoa ushahidi wa ziada wa ufanisi wa kutumia corticosteroids moja kwa moja kwenye vidonda vya HS (hidradenitis suppurativa) na vidonda vilivyojanibishwa. Zaidi ya hayo, kuna ushahidi unaopendekeza kwamba kutumia tetracycline pekee kunaweza kuwa na ufanisi sawa na kuchanganya clindamycin na rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Matibabu mengi hutumiwa kwa hidradenitis suppurativa, ikiwa ni pamoja na antibiotics, retinoids, antiandrogens, dawa za kudhibiti kinga (immune‑suppressing drugs), dawa za kupambana na uchochezi (anti‑inflammatory medications), na radiotherapy kwa vidonda vya mapema. Tiba zinazopendekezwa zaidi ni adalimumab na tiba ya laser. Upasuaji, ama upasuaji rahisi au ukataji kamili wa ndani kwa kuunganisha ngozi, ndilo chaguo linalopendelewa kwa kesi kali, za hali ya juu ambazo haziitikii vyema matibabu mengine.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Sababu hasa kwa kawaida haijulikani, lakini inaaminika kuhusisha mchanganyiko wa mambo ya kijenetiki na kimazingira. Takriban theluthi moja ya watu walio na ugonjwa huo wana jamaa walioathirika. Sababu nyingine za hatari ni pamoja na fetma na kuvuta sigara. Hali hiyo haisababishwa na maambukizi, usafi usiofaa.
Hakuna tiba inayojulikana. Kukata vidonda vya wazi ili kuruhusu kukimbia haitoi faida kubwa. Ingawa antibiotics hutumiwa kwa kawaida, ushahidi wa matumizi yao ni duni. Dawa za immunosuppressive (Immunosuppressive medications) pia inaweza kujaribiwa. Kwa wale walio na ugonjwa mbaya zaidi, tiba ya laser au upasuaji wa kuondoa ngozi iliyoathiriwa inaweza kuwa hai. Mara chache, kidonda cha ngozi kinaweza kuwa saratani ya ngozi.
Ikiwa kesi ndogo za hidradenitis suppurativa (Hidradenitis suppurativa) zinajumuishwa, basi makadirio ya mzunguko wake ni kutoka kwa 1‑4 % ya idadi ya watu. Wanawake wana uwezekano mara tatu zaidi wa kugunduliwa kuliko wanaume. Kawaida huanza katika ujana.